Radioprotective Effect of American Ginseng on Human Lymphocytes at 90 Minutes Post-irradiation: A Study of 40 Cases by Lee, Tung-Kwang et al.
Radioprotective Effect of American Ginseng on Human
Lymphocytes at 90 Minutes Post-irradiation: A Study of 40 Cases
Tung-Kwang Lee, MD1,*, Kevin F. O’Brien, PhD2, Weidong Wang, MD, PhD1,3, Roberta M.
Johnke, PhD1, Chao Sheng, PhD1, Sidi M. Benhabib1, Tao Wang, MD, PhD4, and Ron R.
Allison, MD1
1Department of Radiation Oncology, Leo W. Jenkins Cancer Center, Brody School of Medicine at
East Carolina University, Greenville, NC 27834, USA
2Department of Biostatistics, School of Allied Health, East Carolina University, Greenville, NC
27834, USA
3Department of Oncology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037,
China
4Department of Anatomy and Cell Biology, Brody School of Medicine at East Carolina University,
Greenville, NC 27834, USA
Abstract
Background—Ionizing radiation (IR) initiates intracellular oxidative stress through enhanced
formation of reactive oxygen species (ROS) that attack DNA leading to cell death. As the diversity
of IR applied in medicine, agriculture, industry, and the growing threats of global terrorism, the
acquisition of radioprotectors is an urgent need for the nation. However, the applicability of
radioprotectors currently under investigation is limited due to their inherent toxicity.
Objective—This study investigated the effect of a standardized North American ginseng extract
(NAGE, total ginsenoside content: 11.7%) on DNA damage in human lymphocytes at 90 min post-
irradiation.
Design—With the application of NAGE (250 – 1000 µg ml−1) at 90 min post-irradiation (1 and 2
Gy), DNA damage in lymphocytes obtained from 40 healthy individuals was evaluated by
cytokinesis-block micronucleus (CBMN) assay. Similar experiments were also performed in
lymphocytes treated with WR-1065 (1 mM or 3mM). In addition, before and after irradiation,
lymphocytes obtained from 10 individuals were measured for their total antioxidant capacity (TAC)
and the reactive oxygen species (ROS).
Results—The significant effect of NAGE against 137Cs-induced MN in lymphocytes is
concentration-dependent. NAGE (750 µg ml−1) reduced MN yield by 50.7% after 1 Gy and 35.9%
after 2 Gy exposures, respectively; these results were comparable to that of WR-1065. Further, we
also found that NAGE reduces MN yield and ROS but increases TAC in lymphocytes.
Conclusions—Our results suggest that NAGE is a relatively non-toxic natural compound that
holds radioprotective potential in human lymphocytes even when applied at 90 min post-irradiation.
One of the radioprotective mechanisms may be mediated through the scavenging of free radicals and
enhancement of the intracellular TAC.
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Introduction
It is well known that exposure of normal tissue cells to ionizing radiation (IR) activates genetic
cascades of signaling events, generating free radicals collectively known as reactive oxygen
species (ROS), which attack DNA, ultimately leading to cell death. Due to the increased
utilization of IR in human life and the growing threats of global terrorism, IR-induced normal
tissue morbidities are of further importance to both civilians and military populations, since
they are potentially subject to accidental or intentional nuclear mishaps. Hence, the
development of efficacious radioprotector would be a contribution to radiation oncology,
public health, national defense, and environmental remediation.1–3
The term “radioprotector” primarily refers to free radical scavengers that avert the initial
radiochemical events in cells following IR exposure. Currently, the majority of potential
radioprotective chemical compounds under investigation are designed to scavenge IR-induced
free radicals. Nevertheless, their efficacy is linked to high-drug dosages that will evoke
unacceptable side effects, and none of these agents is available for human use outside the clinic.
2 Thus, the search for less- or nontoxic agents to counter the effects of IR remains an area of
intense focus.1,2 Natural products such as herbal medicines with an abundance of antioxidant
resources have received attention as possible radiation modifiers.4
Herbal medicine, or phytomedicine, is generally considered a well-established form of
complementary medicine. Ginseng is one of the most frequently purchased herbs in the US
marketplace and is frequently taken orally as a traditional herbal medicine.5 The term ginseng
refers to the dried root of several species in the plant genus Panax, which belongs to the
Araliaceae family; it comprises two commonly used ginseng species, i.e., Panax ginseng C.A.
Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). These two
forms of ginseng have drawn worldwide attention for their broad medicinal potential, such as
antiaging, antidiabetic, anticarcinogenic, antihypertension, antipyretic, antistress, analgesic,
and antifatigue effects, as well as their enhancement of immune response to polyclonal
stimulation and promotion of DNA, RNA, and protein synthesis.5–9 Recently, in a 18.8 years
cohort study based on 6282 human subjects, Yi et al found that ginseng intake significantly
decreased all-cause martality in older Korean males.5 The predominant bioactive components
of ginseng are a diverse group of triterpenoid saponins with steroidal structures, labeled
ginsenosides. Although the mechanisms are still largely unknown, the medicinal properties of
ginseng have been closely related to the effects of ginsenosides against free radical attack. 6–
8,10
After the exposure of mammalian cells to ionizing radiation (IR), an unregulated production
of ROS, associated with a shift in the intracellular oxidant-antioxidant balance towards a pro-
oxidant state, triggers damage to cellular membranes and DNA, leading to a state of oxidative
stress. However, because effective antioxidants are free radical scavengers that interfere with
radical chain reactions, it is possible to protect cellular DNA from oxidative stress by
supplementation with antioxidants. 11–14
Studies of the radioprotective effect of ginseng have been performed primarily with the
application of Asian ginseng in rodent models. 8,15 Micronuclei (MN) in interphase
mammalian cells are reliable biomarkers for evaluating IR-induced chromosome damage.16,
17 We recently found that incubation with Asian ginseng dried root crude water extract (100
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µg-2000 µg ml−1) 24 h before 137Cs exposure significantly reduced radiation-induced (MN)
yield in peripheral blood lymphocytes (PBL) obtained from four human subjects.18 However,
although North American ginseng (NAG) is one of the best-selling herbs on the market, relative
few studies have involved NAG.8 The purpose of this study was to investigate whether
radioprotective effect of a standardized North American ginseng extract (NAGE) could also
be achieved in human PBL when applied postradiation. The hypotheses behind this study are
(1) that IR-induced oxidative injury in PBL is preventable by the administration of exogenous
antioxidants; and (2) that the radioprotective effect of NAGE on human PBL is a result of
modulation of the activity of the intracellular antioxidant defense systems. To test these
hypotheses, we investigated the impact of NAGE when applied 90 min after 137Cs exposure
on MN yield in PBL obtained from 40 healthy individuals. The MN results in PBL obtained
from NAGE application were compared with similar experiments using WR-1065, the
biologically active aminothiol form of amifostine (WR-2721), which is currently the only “gold
standard ” of radioprotectors approved by the US Food and Drug Administration.19,20 In
addition, in ten of these individuals, we also evaluated the correlation between the effect of
NAGE on intracellular total antioxidant capacity (TAC), levels of ROS production, and MN
yield in PBL before and after 137Cs exposure. Although preliminary, we believe that the
information generated from these in vitro studies will provide the foundation for in vivo trials
to assess the potential of NAGE as a natural dietary radiation countermeasure.
Materials and Methods
Subjects
Our University Medical Center Institutional Review Board approved this study. A total of 40
healthy individuals (23M/17F) 43.3 ± 2.2 (mean ± SEM) years of age, without known history
of exposure to mutagens, were recruited in this study. No individuals were currently taking
any other pharmacologic agents, including medications, vitamins, or dietary supplements. All
participants signed informed consent before enrollment.
NAGE preparation and ginsenosides content
The standardized NAGE powder (Lot-TKGS-010406) was purchased from Canadian
Phytopharmaceuticals Corporation (Richmond, BC, Canada). Using high-performance liquid
chromatography, the major ginsenosides in this NAGE powder were characterized by the
vendor as follows: Rb1 (5.1%), Rb2 (0.99%), Rc (1.88%), Rd (1.23%), Re (2.14%), and Rg1
(0.36%) with total ginsenoside content (w/w) of 11.7%. To ensure stability, the NAGE was
stored in a cool, dry, dark location over the course of the study. Before experimentation, 50
mg of the lyophilized NAGE powder was dissolved in 5 ml 1× RPMI culture medium (Sigma-
Aldrich, MO, USA), filtered through a 0.2 µm disc (Millipore, MA) under sterile conditions,
and was used as the stock solution.
Cytokinesis-block (CB) MN assay
Fresh peripheral blood samples were drawn from each individual into Vacutainer Cell
Preparation Tubes (Becton-Dickson, NJ, USA). Mononuclear cells were isolated by density
gradient centrifugation at 1800 g for 20 min, washed, and counted on a hemacytometer. Trypan
blue exclusion showed the viability to be greater than 95%. The purity of mononuclear cells
was >95% as determined by Hema-3 staining (Fisher Scientific, NC, USA). For each culture,
2–3 × 105 cells ml−1 were incubated in polystyrene culture tubes containing 1× RPMI 1640
culture medium (Sigma Chemical, MO, USA), supplemented with 10% fetal calf serum, L-
glutamine (0.03%), and penicillin (100 IU ml−1) and streptomycin (100 µg ml−1). The final
volume of each culture was 1 ml. Duplicate cultures were set up for each experimental point
within 60 min after venipuncture. Phytohemaglutinin (PHA, M Form, Invitrogen Corp. CA,
USA) was added to each culture (15 µl ml−1) immediately after ex vivo radiation exposure.
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Cytochalasin B (Sigma Chemical, MO, USA) was applied at 44 h after the PHA stimulation,
with a final concentration of 4 µg ml−1. All cultures were maintained in a humidified
atmosphere of 5% CO2 at 37°C following another 24 h and cells were collected by
centrifugation at 300 g for 10 min. The slides, prepared according to the method of Fenech et
al,16,17 were stained with Hema-3 (Fisher Scientific, NC, USA).
Application of NAGE
To ascertain the optimum radioprotective dose of NAGE, a series of preliminary studies were
carried out (Data not shown). Treatment of PBL with NAGE at 500 – 750 µml−1 at 0 h was
found to cause a significant reduction in 137Cs-induced MN yield. Therefore, for the
determination of a dose-response radioprotective effect of NAGE, in each experiment, four
different concentrations (250, 500, 750, and 1000 µg ml−1) of NAGE were applied to
mononuclear cell cultures (2 × 105 cells ml−1) in RPMI 1640 90 min after exposure to 137Cs-
irradiation for CBMN assay.
WR-1065 preparation and application
WR-1065 was kindly provided by Dr. Robert J. Schultz (Drug Synthesis and Chemistry Branch,
NIH-NCI, Bethesda, MD, USA). A stock solution (10 mM) of WR-1065 was made up with
RPMI 1640 culture medium and was kept frozen. The stock solution was thawed on ice
immediately before use and was filtered through a 0.2 µm disc (Millipore, MA), the remainder
was quickly frozen again after use.
For each experimental condition, we serially diluted the stock solution of WR-1065 with the
culture medium to the final concentrations (1 mM or 3 mM). We then applied WR-1065 (1
mM or 3 mM) to mononuclear cell cultures (6 × 105 cells ml−1) at 90 min post irradiation. After
the 10 min treatment with WR-1065, the cell cultures were centrifuged, washed with
phosphate-buffered saline (PBS) to remove the WR-1065, and were resuspended in the RPMI
1640 culture medium for the completion of the CBMN assay.
Ex vivo irradiation
The human G0 PBL were exposed ex vivo to 137Cs γ-rays (Gamma Cell 40, Radiation
Machinery, Ontario, Canada) with 1 or 2 Gy (0.6 Gy/min) at room temperature (22° C), and
NAGE was applied to the culture medium 90 min after irradiation.
Microscopy
Slides were coded and randomized to ensure anonymity upon scoring. For consistency, the
microscopy was performed by one researcher (WW). Under 400× magnification, in continuous
fields from two slides prepared for each experimental checkpoint, he scored a minimum of
1000 binucleated (BN) cells where possible. The quantification of MN yield was restricted to
BN cells with distinct intact cytoplasm and included those with nuclear bridges. MN with
smooth edges touching the main nucleus and those with clearly defined overlap were also
included in the count. The distribution of MN number in each BN cell was also recorded. The
MN yield was determined as MN yield = (Total number of MN in BN cells/Total number of
scored BN cells) × 1000. Percentage reduction of MN was determined as 137Cs-induced MN
yield in varying concentrations of NAGE compared to that with radiation alone.
Measurement of the intracellular total antioxidant capacity (TAC) in PBL
In addition to their CBMN assay, blood samples obtained from 10 (6M/4F, 42.7 ± 4.6 years
of age) of the 40 individuals were studied to determine the intracellular TAC level in PBL.
Using the Antioxidant Assay Kit (Sigma, CS-0790), PBL (1 × 106 cells ml−1) before and at 90
min post irradiation, were incubated with different concentrations of NAGE for 24 h for the
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determination of intracellular TAC. The antioxidant assay is based on the formation of a ferryl
myoglobin radical from myoglobin and hydrogen peroxide, which oxidizes ABTS [2,2’-
azinobis-(3-ethyl-benzothialozine-6-sulfonic acid)] to produce a radical cation ABTS+, a
soluble green chromogen that can be determined at 405 nm. In the presence of antioxidants,
the radical cation is suppressed to an extent dependent on antioxidant activity, and the color
intensity is decreased proportionally. Trolox, a water-soluble vitamin E analogue, served as a
control antioxidant. In brief, at the end of the 24 h incubation, PBL were sonicated on ice in 1
ml of cold 1× assay buffer and centrifuged at 12000 g for 15 min (4°C). In a 96-well culture
plate, the supernatant of PBL lysates (10 µl) in each well was mixed with 1× myoglobin
working solution (20 µl), ABTS substrate working solution (150 µl), and 3% hydrogen
peroxide (25 µl) and allowed to incubate at 25°C for 30 min. For the Trolox standard curve,
10 µl of a Trolox standard and 20 µl of myoglobin working solution were added to each well.
Kit stop solution (100 µl) was then added to each well. Samples were read immediately at 406
nm excitation/530 nm emission on a plate reader. Results were calculated using a reference
curve based on Trolox as a standard, and intracellular TAC in PBL was expressed in mM
Equivalent/L.
Measurement of intracellular oxidative stress in PBL
In addition to their CBMN assay, blood samples obtained from 10 (6M/4F, 42.7 ± 4.6 years
of age) of the 40 individuals were studied to determine the intracellular ROS level in PBL. In
brief, using the Live Cell Fluorescent Reactive Oxygen Species Detection Kit (MGT-M1049,
Marker Gene Technologies, Eugene, OR), before and at 90 min post 137Cs exposure, PBL (1
× 106 cells ml−1) were incubated with different concentrations of NAGE for 24 h. At the end
of the incubation, the culture medium was aspirated after centrifugation (1000 g, 15 min) and
pellets were suspended in ROS inducer, i.e. t-butyl hydroperoxide (TBHP) working solution
(100 µM), then incubated for 60 min at 37°C. After centrifugation, PBL pellets were
resuspended and incubated in darkness for 45 min in 2’,7”-dichlorofluorescein diacetate (25
µM), which is a cell-permeable substrate and a reliable fluorogenic marker for ROS detection.
Upon enzyme activity, the highly fluorescent dye, 2’,7”-dichlorofluorescein was produced.
The cellular fluorescence from each well was determined using 480 nm excitation/535 nm
emission with a microplate spectrofluorometer. The values of fluorescence intensity, reflecting
the intracellular concentration of ROS in PBL, were expressed as percentage of controls.
Statistical analyses
All measurements were represented as the mean and standard error of the mean (± SEM) and
were blinded as to subject status. We used the software package SPSS for the data analysis.
21 Statistical methods consisted of repeated measures of ANOVA and linear regression using
a mixed-model approach with random intercepts. Linear contrasts were used to examine the
effect of NAGE (0 – 1000 µg ml−1) on radiation-induced MN yield in PBL and were completely
cross–classified in a factorial fashion. The effect of radiation on MN yield of PBL in the
presence and absence of NAGE, and the interactions between radiation doses and
concentrations of NAGE were evaluated separately. Associations between MN yield and
intracellular TAC and ROS levels in PBL were assessed by Pearson’s correlation test.
Results
Effect of NAGE and WR-1065 on MN yield in PBL before 137Cs exposure (Table 1)
Before irradiation and in the absence of both NAGE and WR-1065, mean (± SEM) baseline
MN yield of PBL obtained from the 40 healthy individuals was 16.7 ± 0.9 per 1000 BN cells.
The presence of NAGE (250 – 1000 µg ml−1) or WR-1065 (1mM or 3 mM) in PBL culture
medium did not affect the MN yield significantly.
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Effect of NAGE and WR-1065 applied at 90 min after 137Cs exposure on MN yield in PBL
Radiation alone (1 Gy and 2 Gy) sharply increased the MN yield in PBL in a dose-dependent
manner (Table 2, P<0.001). However, both NAGE (250 – 1000 µg ml−1) and WR-1065
(1mM or 3 mM) significantly reduced the MN yields as their concentration increased (Table
1). The best-fitting line for this relationship was Y = C + αD + βD2 (Table 2, P<0.001), where
Y is the MN per 1000 BN cells and C is the intercept, D is the concentration of NAGE or
WR-1065, and α and β are the linear and quadratic coefficients, respectively. Table 1 shows
that, when compared with radiation alone, application of NAGE (750 µg ml−1) reduced MN
yield by 50.7% after 1 Gy and 35.9% after 2 Gy exposure, respectively; the application of
WR-1065 (3 mM) reduced MN yield by 52.0% after 1 Gy and 33.4% after 2 Gy exposure,
respectively.
Effect of NAGE applied before and 90 min after 137Cs irradiation on intracellular TAC status
(mM Trolox equivalent/L) in PBL
Fig 1B illustrates the variations of intracellular TAC levels in PBL obtained from 10 health
individuals. Before 137Cs irradiation and in the absence of NAGE in the PBL culture medium,
the baseline TAC level in PBL was 1.0 ± 0.1. However, it increased in PBL before irradiation
with increments in NAGE concentration (250–1000 µg ml−1) in a concentration-dependent
manner (P<0.001). In contrast, IR exposure of PBL results in a decline in the intracellular TAC
level in PBL. After 137Cs exposure (1 Gy and 2 Gy) of PBL, baseline TAC levels in PBL
decreased with increasing radiation dose (P<0.001). When NAGE was applied to the culture
medium 90 min after radiation exposure, as compared with radiation alone (1 Gy and 2 Gy),
TAC levels in irradiated PBL increased significantly (P<0.01).
Effect of NAGE on intracellular ROS status (% of Control) in PBL before and 90 min
after 137Cs irradiation (Fig. 1C)
Before irradiation and in the absence of NAGE in the PBL culture medium, baseline fluorescent
ROS level in PBL obtained from 10 healthy individuals was 11.1 ± 2.2. IR exposure of PBL
results in an increase in the intracellular ROS level in PBL. The ROS level in irradiated PBL
increased significantly with radiation dose to 62.5 ± 6.6 after 1 Gy and 85.3 ± 6.6 after 2 Gy
exposure. However, when NAGE was applied to culture medium 90 min post exposure, the
intracellular ROS level in irradiated PBL decreased significantly with the NAGE concentration
(P<0.001).
Discussion
In this ex vivo study of peripheral blood lymphocytes (PBL) obtained from 40 healthy human
subjects, we have demonstrated the potential of a standardized North American ginseng extract
(NAGE) and WR-1065 to modulate 137Cs-induced oxidative stress in PBL at 90 min after
exposure, thereby indicating their post-exposure radioprotective effect. The cell membrane of
PBL has very high phospholipid content, rendering PBL vulnerable to oxidative damage.7
Micronuclei (MN) formation in PBL is a well-established biomarker for radiation-induced
damage and free radical impacts.22 We irradiated PBL with 1 – 2 Gy, because this dose range
induces significant DNA damage, without the possibility of instant killing or causing selective
interphase cell death.
The radioprotective effect and the antioxidative potentials of ginseng are no longer novel
findings;15,18,23,24 nevertheless, to the best of our knowledge, no published data has ever been
used to analyze the effect of NAGE on intracellular oxidant-antioxidant homeostasis in human
PBL after irradiation. We made three interesting findings in this study. First, at 90 min post
irradiation, both NAGE and WR-1065 significantly reduced the 137Cs-induced MN yields in
a concentration-dependent manner (Table 1 and Table 2). This relatively long postirradiation
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protective window of the two agents could be of potential clinical interest if it is upheld in in
vivo studies.
Second, we also found that at 90 min post irradiation, the maximum reduction rates by NAGE
(750 ug ml−1) and WR (3 mM) of MN yields in PBL were 50.7% and 52% after 1 Gy and
35.9% and 33.4% after 2 Gy irradiation, respectively (Table 1). These results suggest the
potential of NAGE against radiation-induced MN production in PBL is comparable to that of
WR-1065. In addition, at concentrations up to 1000 µg ml−1 (NAGE) or 3 mM (WR-1065),
respectively, no modulation of MN yield was found in PBL before irradiation (Table 1),
indicated that this protection is accomplished without apparent genomic toxicity in PBL.
Third, we further observed in PBL obtained from 10 human subjects that the rise in 137Cs-
induced MN yields in PBL is paralleled by the ROS level at the time of irradiation in a radiation
dose-dependent manner (P=0.03– 0.005) , but is inversely correlated with the reduction of
TAC (P=0.005 – 0.001) (Fig. 1A–C). This finding suggests that the existing endogenous
antioxidants in PBL were not able to counteract the 137Cs-induced oxidative stress, and thus
the increased MN production was a function of ROS accumulation and DNA damage.
However, with the application of NAGE to the culture medium (250 – 1000 µg ml−1) at 90
min post irradiation, the observed significant increase in intracellular TAC level and
concomitant decrease of both MN yield and ROS level strongly indicate a restoration of
antioxidant capacity in PBL by NAGE treatment.
The exact mechanism underlying the post-exposure radioprotective effect of NAGE is unclear.
Like WR-1065 in part by the upregulation of the manganese superoxide dismutase (SOD2)
gene,19,25,26 ginseng confers radioprotection by scavenging IR-induced ROS. Since the
molecular components of ginseng responsible for this scavenging action are ginsenosides7,8,
the radioprotective potential of ginseng is likely directly related to its ginsenoside content,
which is quite high in our NAGE formulation (11.7%). Ginsenosides in NAGE are capable of
intercalating in the plasma membrane, leading to changes in membrane fluidity and eliciting
a cellular response to IR-induced cytotoxic stress.27 We found in this study that the application
of NAGE to the culture medium at 90 min post 137Cs exposure, significantly increased
intracellular TAC levels and was accompanied by a significant decrease in both ROS and MN
yields in PBL (Fig.1). Under our experimental design, the intracellular TAC in PBL represents
the cumulative antioxidant capacity, including both NAGE-derived antioxidants and those of
endogenous origin. Our findings suggest that (1) the lipid-soluble and water-soluble
antioxidant of NAGE permeate into PBL and suppress 137Cs-induced MN and ROS via OH
radical scavenging; (2) this action could be occurring directly through free radical scavenging
or indirectly through upregulation of antioxidant enzymes.10,28 Based on our findings
concerning antioxidant activity at cellular level, it appears that the post-exposure protection of
NAGE may be due either to its potential for modulating the redox homeostasis or for boosting
the intracellular antioxidant defense system in human PBL.
Our findings are in agreement with the belief that supplementation of antioxidants could inhibit
the ROS-induced DNA damage in human PBL.13 However, our results were generated from
ex vivo experiments after up to 2 Gy irradiation of PBL. Also, the antioxidant capacities of
NAGE measured ex vivo may not be consistent with their effects in vivo. For instance, after
oral ingestion of ginseng, both gastric digestion and hydrolysis by intestinal microflora lead
to the biotransformation of ginsenosides 29. Subsequently, ginsenoside metabolites can be
absorbed into the blood, whence they can exert their active pharmacological effects. Since
intestinal bacteria are sensitive to host conditions, the individual physiological variations in
bacteria-hydrolyzing potentials may affect the radioprotective efficiency of NAGE. Thus, the
clinical relevance of our findings that the concentration of NAGE at 750 µg ml−1 reduced both
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MN yields and ROS levels in human PBL ex vivo (Table 1, Fig. 1) would be hard to predict.
We are planning to answer these questions in a future research project.
Currently, amifostine (WR-2721) is the only radioprotective agent approved by the FDA for
cancer patients undergoing radiotherapy. However, the limitations associated with amifostine
include its inherent toxicity, high cost, intravenous administration route to be applied 15 min
before radiotherapy, and possible tumor protection.1,2,30 In contrast, NAGE is a relatively
non-toxic, inexpensive natural product with broad medicinal and pharmacological activities,
including antitumor activity that can be orally administered under emergency conditions or as
a dietary supplement. We believe, therefore, that NAGE is a candidate eminently suited for
addition to the list of potential radioprotectors.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This research was supported by NIH/NCCAM grant R21-AT002639-02. We are grateful to Miriam Wildeman, M.D.
for her dedications in editing and proofreading of this manuscript; and to Mark Harrington for his technical support.
Our sincere appreciation also extends to the healthy volunteers who gave their blood to make this study possible, and
to the reviewers for their constructive suggestions.
References
1. Moulder JE. Report on an interagency workshop on the radiobiology of nuclear terrorism. Molecular
and cellular biology of moderate dose (1 – 10 Sv) radiation and potential mechanisms of radiation
protection (Bethesda, Maryland, December 17–18, 2001). Radiat Res 2002;158:118–124. [PubMed:
12071812]
2. Stone HB, Moulder JE, Coleman CN, et al. Models for evaluating agents intended for the prophylaxis,
mitigation and treatment of radiation injuries report of an NCI workshop, December 3–4, 2003. Radiat
Res 2004;162:711–728. [PubMed: 15548121]
3. Pellmar TC, Rockwell S. Radiological/Nuclear Threat Countermeasures Working Group. Priority list
of research areas for radiological nuclear threat countermeasures. Radiat Res 2005;163:115–123.
[PubMed: 15606315]
4. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and
phytochemicals. Toxicol 2003;189:1–20.
5. Yi SW, Sull JW, Hong JS, et al. Association between ginseng intake and mortality: Kangwha cohort
study. TJ Altern Complement Med 2009;15:921–928.
6. Kitts DD, Hu C. Efficacy and safety of ginseng. Pub Health Nutri 2000a;4A:473–485.
7. Block KI, Mead MN. Immunesystem effects of Echinacea, ginseng, and astragals: A review. Interg
Cancer Therap 2003;2:247–267.
8. Lee TK, Johnke RM, Allison RR, et al. The radioprotective potential of ginseng. Mutagenesis
2005;20:237–243. [PubMed: 15956041]
9. Lee SH, Ahn YM, Ahn SY, et al. Interaction between Warfarin and Panax ginseng in ischemic stroke
patiens. TJ Altern Complement Med 2008;14:715–721.
10. Kitts DD, Wijewickreme AN, Hu C. Antioxidant properties of a North American ginseng extract.
Molec Cell Biochem 2000b 203;:1–10.
11. Lemon JA, Rollo CD, Boreham DR. Elevated DNA damage in a mouse model of oxidative stress:
impacts of ionizing radiation and a protective dietary supplement. Mutagenesis 2008;23:473–482.
[PubMed: 18644833]
12. Møller P, Loft S. Interventions with antioxidants and nutrients in relation to oxidative DNA damage
and repair. Mutat Res 2004;551:79–89. [PubMed: 15225583]
Lee et al. Page 8
J Altern Complement Med. Author manuscript; available in PMC 2010 May 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
13. Møller P, Loft S. Dietary antioxidants and beneficial effect on oxidatively damaged DNA. Free Rad
Biol Med 2006;41:388–415. [PubMed: 16843820]
14. Dusinska M, Collins AR. The comet assay in human biomonitoring: gene-environment interactions.
Mutagenesis 2008;23:191–205. [PubMed: 18326867]
15. Lee HJ, Kim SR, Kim JC, et al. In vivo radioprotective effect of Panax ginseng C.A. Meyer and
identification of active ginsenosides. Phytother Res 2006;20:392–395. [PubMed: 16619368]
16. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res 1985;147:29–36.
[PubMed: 3974610]
17. Fenech M, Denham J, Francis W. Micronuclei in cytokinesis-blocked lymphocytes of cancer patients
following fractionated partial-body radiotherapy. Int J Radiat Biol 1990;57:373–384. [PubMed:
1968501]
18. Lee TK, Allison RR, O’Brien KF, et al. Ginseng reduces the micronuclei yield in lymphocytes after
irradiation. Mutat Res 2004;557:75–84. [PubMed: 14706520]
19. Dziegielewski J, Baulch JE, Goetz W, et al. WR-1065, the active metabolite of amifostine, mitigates
radiation-induced delayed genomic instability. Free Rad Biol Med 2008;45:1674–1681. [PubMed:
18845240]
20. Walker DM, Kajon AE, Torres SM, et al. WR1065 mitigates AZT-ddl-induced mutagenesis and
inhibits viral replication. Environm Mol Mutagen 2009;50:460–472.
21. SPSS. Base 10.0 Application Guide. Chicago, IL: SPSS Inc; 2001.
22. Greenrod W, Fenech M. The principal phenolic and alcoholic components of wine protect human
lymphocytes against hydrogen peroxide- and ionizing radiation-induced DNA damage in vitro.
Mutagenesis 2003;18:119–126. [PubMed: 12621066]
23. Lee LS, Wise SD, Chan C, et al. Possible differential induction of phase 2 enzyme and antioxidant
pathways by American ginseng, Panax quinquefolius. J Clin Pharmacol 2008;48:599–609. [PubMed:
18319359]
24. Kim TK, Yoo KM, Lee JW, et al. Protective effect of steamed American ginseng (Panax
quinquefolius L.) on V79-4 cells induced by oxidative stress. J Ethnopharmacol 2007;111:443–450.
[PubMed: 17276636]
25. Murley JS, Nantajit D, Baker KL, et al. Maintenance of manganese superoxide dismutase (SOD2)-
mediated delayed radioprotection induced by repeated administration of the free thiol form of
amifostine. Radiat Res 2008;169:495–505. [PubMed: 18439041]
26. Murley JS, Kataoka Y, Weydert CJ, et al. Delayed cytoprotection after enhancement of Sod2
(MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active
metabolite of amifostine. Radiat Res 2002;158:101–109. [PubMed: 12071809]
27. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology. Biochem Pharmacol 1999;58:1685–1693.
[PubMed: 10571242]
28. Xie JT, Shao ZH, Vanden Hoek TL, et al. Antioxidant effects of ginsenoside Re in cardiomyocytes.
Eur J Pharmacol 2006;532:201–207. [PubMed: 16497296]
29. Hasegawa H. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic
activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid. J
Pharamcol Sci 2004;95:153–157.
30. Grdina DJ, Murley JS, Kataoka Y, et al. Radioprotectors: Current status and new directions. Radiat
Res 2005;163:704–705. [PubMed: 16044505]
Lee et al. Page 9
J Altern Complement Med. Author manuscript; available in PMC 2010 May 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Lee et al. Page 10
J Altern Complement Med. Author manuscript; available in PMC 2010 May 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Lee et al. Page 11
Ta
bl
e 
1
C
om
pa
ris
on
 o
f t
he
 e
ff
ec
t o
f N
A
G
E 
(µ
g 
m
l−
1 )
 a
nd
 W
R
-1
06
5 
(m
M
) a
pp
lie
d 
90
 m
in
 p
os
t i
rr
ad
ia
tio
n 
on
 13
7 C
s-
in
du
ce
d 
M
N
 y
ie
ld
 (p
er
 1
00
0 
B
N
 c
el
ls
) i
n
ly
m
ph
oc
yt
es
 o
bt
ai
ne
d 
fr
om
 4
0 
he
al
th
y 
in
di
vi
du
al
s. 
Pe
rc
en
ta
ge
 re
du
ct
io
n 
an
d 
si
gn
ifi
ca
nc
e 
of
 d
iff
er
en
ce
 w
er
e 
de
te
rm
in
ed
 a
s 1
37
C
s-
in
du
ce
d 
M
N
 y
ie
ld
 in
va
ry
in
g 
co
nc
en
tra
tio
ns
 o
f N
A
G
E 
an
d 
W
R
-1
06
5 
co
m
pa
re
d 
to
 th
at
 o
f r
ad
ia
tio
n 
al
on
e.
G
y
N
A
G
E
M
N
G
y
W
R
-1
06
5
M
N
M
ea
n
SE
M
R
ed
uc
tio
n 
(%
)
M
ea
n
SE
M
R
ed
uc
tio
n(
%
)
0
0
16
.7
*
0.
9
-
0
0
16
.7
0.
9
-
25
0
14
.4
1.
3
-
1 
m
M
15
.6
1.
3
-
50
0
15
.6
1.
4
-
3 
m
M
15
.9
1.
8
-
75
0
10
.5
1.
2
-
10
00
14
.2
1.
0
1
0
11
1.
4*
†
4.
4
-
1
0
11
1.
4#
4.
4
-
25
0
89
.7
†
7.
5
19
.5
1m
M
63
.9
#
5.
9
42
.6
50
0
71
.1
†
3.
6
36
.2
3 
m
M
53
.5
#
5.
6
52
.0
75
0
54
.9
†
8.
1
50
.7
10
00
69
.1
†
4.
7
38
.0
2
0
21
2.
8*
‡
6.
9
-
2
0
21
2.
8*
*
6.
9
-
25
0
17
2.
2‡
12
.5
19
.1
1m
M
13
1.
4*
*
12
.5
38
.3
50
0
15
9.
5‡
9.
0
25
.0
3m
M
14
1.
8*
*
16
.7
33
.4
75
0
13
6.
4‡
12
.8
35
.9
10
00
13
9.
6‡
8.
5
34
.4
*‡
**
P<
0.
00
1
†#
P<
0.
01
J Altern Complement Med. Author manuscript; available in PMC 2010 May 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Lee et al. Page 12
Table 2
Regression coefficients of 137Cs dose-response relationship of MN yield in BN lymphocytes obtained from
healthy individuals (n = 40) when NAGE or WR-1065 applied to the culture medium 90 min after the radiation
exposure.
Gy Intercept Slope Curvature
NAGE 0 14.0* 1.53E-3 −2.94E-6
WR-1065 0 15.3* 2.59E-1 −3.00E-2
NAGE 1 123.0* −1.65E-1* 1.17E-4*
WR-1065 1 130.5* −8.72E+1* 2.05E+1*
NAGE 2 194.6* −1.47E-1* 7.03E-5
WR-1065 2 241.7* −1.49E+2* 3.85E+2*
*
(P<0.001)
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